3.8 million Russians were fully vaccinated with Sputnik V

Photo of author

By admin

Two components of the Sputnik V coronavirus vaccine were received by 3.8 million residents of Russia. This was announced on April 19 by the deputy director of the Gamaleya Center for Scientific Work, Denis Logunov.

“At the moment, 3.8 million people have been vaccinated in Russia and entered into the database at least twice,” Logunov said during a general meeting of the Medical Sciences Department of the Russian Academy of Sciences (RAS).

Logunov also noted that about 20 million doses of the drug for coronavirus were produced in Russia, 16 million of them went into civil circulation.

During the meeting, the head of Rospotrebnadzor, Anna Popova, also said that 192 cases of the British strain of coronavirus and 21 of the South African were detected in Russia. The head of Rospotrebnadzor added that the country is also forming its own mutations of the virus, which she called the Siberian and northwestern variants.

Popova also announced the need to introduce special measures against COVID-19 in large cities of the Russian Federation.

On April 16, Deputy Prime Minister of the Russian Federation Tatyana Golikova said that the rate of vaccination against coronavirus in Russia is growing, which gives reason to think about the imminent lifting of restrictions imposed on the background of the pandemic. At the same time, she urged the heads of the regions to be careful when making the appropriate decision.

Since January 18, a large-scale vaccination against coronavirus has been taking place in Russia. The vaccination is given free of charge to everyone.

Three vaccines against coronavirus have been registered in the Russian Federation today: Sputnik V, developed by the Gamaleya Center, EpiVacCorona from the Vector Center, and KoviVak from the V.I. Chumakov.

All relevant information on the situation with the coronavirus is available on the websites of stopcoronavirus.rf and access vsem.rf, as well as by the hashtag #WeVotte. Coronavirus hotline: 8 (800) 2000-112.